Abstract

Background

Thymol and its derivatives have been proven in earlier studies to exhibit a broad range of biological activities, particularly given that many of them have therapeutic uses.

Objectives

This study focused on preparing a new ester of thymol, and the new compound was studied as antibacterial, anticancer and as antioxidant agent.

Methodology

Thymol was condensed with indole-3-carboxylic acid in DCM solvent at room temperature (25 °C) without catalyst to form the new thymol ester compound E2 (Fig. 1), and then the new compound was identified through FT-IR and NMR analysis, and the biological properties were tested and studied.

Results

The results showed that the novel E2 ester molecule was variably effective against all tested cancer and bacterial cells in different amounts.

Conclusion

According to this study, thymol ester E2 preserved normal muscle cells more effectively than thymol. In contrast to thymol, the E2 derivative had superior efficacy against the Gram-positive bacteria under investigation (S. aureus and S. epidermis) in the antibacterial trial. Additionally, its inhibition zone was larger than Gentamicin against S. epidermis. Additionally, the E2 ester molecule exceeded thymol in an antioxidant assay for scavenging capacity at low concentrations.

Title

Journal of Molecular Structure

Publisher

Elsevier

Publisher Country

Netherlands

Indexing

Thomson Reuters

Impact Factor

4.0

Publication Type

Both (Printed and Online)

Volume

1334

Year

2025

Pages

--